Dynamic First Quarter in 2015 | Forecast Revised Upwards
In the first quarter of 2015, the Sartorius Group achieved sales growth of around 17% in constant currencies based on preliminary figures, reaching approximately €258 million in consolidated revenue (reported gain: around 27%).
This growth was driven primarily by the Bioprocess Solutions Division. Due to the low prior-year revenue base, the company had expected above-average growth rates for this first quarter. Nevertheless, the gains supported by strong performance in all product segments were higher than projected at the beginning of the year.
Based on the results of the first three months, Sartorius has revised its forecast upwards for the full year of 2015. Sales revenue in constant currencies is now expected to increase by approximately 6% to 9% (previous guidance: approx. 4% to 7%). Management projects that the company‘s underlying EBITDA margin in constant currencies will increase to around 22% (previous guidance: around 21.5%).
Further information will be published as part of the company’s first-quarter reporting activities on April 20, 2015.
Goettingen, Germany, April 14, 2015
This ad hoc announcement contains statements about the future development of the Sartorius Group. The content of these statements cannot be guaranteed as they are based on assumptions and estimates that harbor certain risks and uncertainties. This is a translation of the original German-language ad hoc announcement. Sartorius shall not assume any liability for the correctness of this translation. The original German ad hoc announcement is the legally binding version. Furthermore, Sartorius reserves the right not to be responsible for the topicality, correctness, completeness or quality of the information provided. Liability claims regarding damage caused by the use of any information provided, including any kind of information which is incomplete or incorrect, will therefore be rejected.